De-escalation Strategies for Axillary Surgery in Early-Stage Indolent Breast Cancer

Local Control After Recurrence: When to Do Re-sentinel Biopsy, Re-radiotherapy

Sequencing Systemic Therapy and Local Control for Advanced BCs

Neoadjuvant vs. Adjuvant Chemotherapy for ER+ Breast Cancer

Emerging Option of Neoadjuvant Immunotherapy for ER+ Breast Cancer

Current Status and Future Directions of Neoadjuvant Hormonal Therapy

Screening for Breast Cancer in Korea: Yesterday, Today and Tomorrow

Breast Cancer Screening in China: Policies, Current Status, and Key Challenges

Breast Cancer Screening in India: Policies, Current Status, and Key Challenges

Introduction of OASIS Project

Ongoing and Proposal Trials (KBCSG)

Omission of Adjuvant Endocrine Therapy for ER+T1ab BC

Omission of Axillary Dissection for cN+BC

Ongoing and Proposal Trials (BCT)

The Effect of Axillary Surgery on the Prognosis of IBTR After BCS

What Is the Appropriate Radiation Dose to Axillary Nodes with Prior Metastasis in cN+ Breast Cancer Downstaged to ypN0 After Preoperative Systemic Therapy: A Comprehensive Dosimetric Analysis

Prospective Feasibility Study on Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for Ductal Carcinoma in situ

Is it Necessary to Remove Suspicious Calcification in Hormone Receptor Negative and HER2 Positive Breast Cancer who Received Neoadjuvant Chemotherapy, Especially in Pathologic Complete Response

Dosimetric parameters of the axillary-lateral thoracic junction as a risk factor for breast cancer-related lymphedema

Utility of Pre-operative Mapping of the Blood Supply to the Nipple Areolar Complex for Individualised Pedicle Planning During Reduction Mammoplasty for Breast Cancer: MAP-NAC, a Cohort Study

Percutaneous Cryoablation with Palliative Intent for Breast Cancer Patients: Feasibility, Safety and Tumor Ablation Rate

Initial Experience on Broadening the Use of Cryoablation on early Breast Cancers

Comparative Incidence Rates and Survival Rates in BRCA-positive patients: A Meta-Analysis of Active Surveillance versus Risk Reduction Mastectomy

Unique Challenges in Breast Cancer for Young Women: What’s Different? 

Endocrine Treatment Strategies for Young Women: Tailoring for Optimal Outcomes

BRCA Mutations in Young Women’s Breast Cancer: Risk, Treatment, and Implications for Family Planning 

Width of Closest Margin: Greater the Safer?

Integration of Margin Status and Subsequent Radiotherapy

Safe Margins for Different Tumor Types?

ER-Low and HER2-Low Breast Cancer: Pathological and Clinical Landscape

Lobular Carcinoma: Current Concepts and Clinical & Therapeutic Implications

Lobular Carcinoma: Radiological Implication

Treatment Inequity in Breast Cancer: Necessity of Global Collaboration

Disparities in Access to Systemic Treatment in Asia

Current Treatment of Breast Cancer in Mongolia

Discussion

Comparing AI-Enhanced Digital Mammography and Digital Breast Tomosynthesis for Interval Breast Cancer Detection: Interim Results from a Multi-Reader, Multi-Case Crossover Trial

Retrospective Evaluation of Interval Breast Cancer Screening Mammograms by Radiologists and AI: Are these Partially Preventable?

Enhancing Breast Cancer Risk Stratification in Women with Dense Breasts: Integrating Sonographic Glandular Tissue Assessment with the Mammography-based Risk Model

Impact of Preoperative Breast MRI on Survival Outcomes for Breast Cancer Patients

Clinical significance of Incidental focal hypermetabolic PET-CT breast lesions

Prognostic Value of Pretreatment 18F -FDG PET/CT Parameters in Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitor Plus Endocrine Therapy

BreastTumor.ai: Artificial Intelligence-powered Diagnosis of Breast Tumour Pathologies Using Histological Images

Three-dimensional HER2 Analysis May Identify more Patients Eligible for Trastuzumab Deruxtecan Compared to Conventional Immunohistochemistry

Improved Understanding, Care and Outcomes for Young Breast Cancer Patients

Breakthroughs in Treatment of HER2 Expressing Metastatic Breast Cancer

First CDK4/6 Inhibitor for HR+/HER2- EBC: Abemaciclib-Increasing the Chance for Cure

Advances in Tailoring Radiation Therapy for Breast Cancer

Case Presentation + Voting

Case Presentation + Voting

Case Presentation + Voting

Discussion

CDK4/6 Inhibitors: Challenges and Beyond

ET-Based Combinations and Novel Agents in HR+/HER2- Advanced Breast Cancer

ADCs in HR+/HER2- Advanced Breast Cancer

Extracellular Vesicle Biomarkers as Tools for Real-Time Monitoring of Drug Resistance in Breast Cancer

Leveraging CRISPR/Cas9-Based ctDNA Assay for Early-Stage Breast Cancer Detection: A Pilot Study

Advancing HER2 Status Profiling of HER2-Low Breast Cancer through Extracellular Vesicle Tumor DNA Detection

Paired Genomic Profiling of Triple Negative Breast Cancer to Understand the Mechanisms of Chemoresistance and Develop Novel Treatment Targets

EDIL3/Del-1-Mediated Phosphorylation of AMPKβ Drives Triple-Negative Breast Cancer Progression

EDIL3+ CAFs Promote Lymph Node Metastasis by Disrupting Lymphatic Endothelial Barriers in Breast Cancer

Reclassification of Germline BRCA1/2 Variants of Uncertain Significance Following Breast Cancer Next Generation Sequencing

Current Technologies in Liquid Biopsy: A Comprehensive Review

Liquid Biopsy in Early Breast Cancer: MRD Monitoring, Early Detection, and Adaptive Therapeutic Decisions

Biomarkers and Resistance in Metastatic Breast Cancer: Tailoring Liquid Biopsy Approaches

Incorporating Comprehensive and Integrative Medicine

Integration of Big Data and AI on Healthcare Research

Digital Clinical Trials-Precision Medicine from Patients

Neurotization in Breast Reconstruction: A Review and Exploration of Ongoing Research

Oncoplastic Surgery: Enhancing Quality of Life Through Cosmetic and Sensory Satisfaction

Abdominal Flap Neurotization: Technical Tips and Outcomes

Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab in Early-Stage TNBC: Overall Survival Results From the Phase 3 KEYNOTE-522 Study in Asian Patients

Discovery of 14-3-3 Proteins YWHAB/YWHAZ as Regulators of CDK4/6 Inhibitor Resistance

Abemaciclib in Combination with Hormonal Therapy for Chemotherapy-Treated Patients With ER+/HER2- Metastatic Breast Cancer

Changes in the Degree of Satisfaction and Quality of Life in Breast Cancer Patients who are Candidates for Breast Conservation but Opted for Mastectomy; A Single-Center Prospective Study

An Educational Video as an Aid in Pre-test Genetic Counselling in a Breast Clinic of a Multicultural Asian City

Adherence to Hormonal Therapy in Breast Cancer Patients: EHR-based Retrospective Data Analysis

Non-pharmacological Interventions for Distress and Anxiety in Patients with Breast Cancer and their Family Caregivers: A Systematic Review and Meta-Analysis